Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
01/2000
01/25/2000US6017762 An ascomycetes fungus strain transformed with a cassette for expressing an aspartic protease precursor; production of cooked cheeses
01/25/2000US6017751 Process and composition for desizing cellulosic fabric with an enzyme hybrid
01/25/2000US6017749 A biological culture capable of producing protease, xylanse and cellulase
01/25/2000US6017747 Nucleic acids encoding a collagenase
01/25/2000US6017745 Enzyme amplification and purification process for producing DNA polymerase
01/25/2000US6017744 Human N-acetyl transferase
01/25/2000US6017743 Dna which codes for a glycosyltransferase which adds oligosialic acids to glycoproteins and glycolipids; for anticarcinogenic/antimetastasis/antiinflammatory agents; for maturation of sperm and reactivation of nervous tissues
01/25/2000US6017732 To screen for enhanced specfic binding pair binding
01/25/2000US6017730 Method of limiting the survival of genetically engineered microorganisms in their environment
01/25/2000US6017728 ribH
01/25/2000US6017726 Efficient process for producing 7-aminodeacetyl-cephalosoporanic acid by culturing penicillium chrysogenum with adipic acid, salt or ester to produce adipoyl-6-aminopenicillanic acid, then enzymatically altering molecule
01/25/2000US6017724 Oxidoreductase and method for preparing 3-(p-hydroxyphenyl)-2-propenol derivatives or the like using the enzyme
01/25/2000US6017708 Human Myt1 protein and chimeric proteins derived therefrom
01/25/2000US6017532 Porphyromonas gingivalis arginine-specific proteinase
01/25/2000US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional,
01/25/2000US6017530 Promoting the growth of a monogastric or polygastric animal and efficiecy of fat digestion
01/25/2000US6017529 A purified human spermidine/spermine n1-acetyltransferase comprising the amino acid sequence of seq id no:1; diagnostic assays; prevention and treatment of cancer
01/25/2000US6017528 Therapeutic treatment of group A streptococcal infections
01/25/2000US6017525 Treating with a composition of non-pathogenic bacteria and enzymes capable of breaking down poultry manure for digestion by the nonpathogenic bacteria along with a carrier; activated by droppings moisture; exclusion of pathogens
01/25/2000CA2184005C Novel phosphoramidate and phophorothioamidate oligomeric compounds
01/25/2000CA2113412C Transgenic plants producing polyhydroxyalkanoates
01/20/2000WO2000003248A1 Method for identifying a presenilinase inhibitor
01/20/2000WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
01/20/2000WO2000003023A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex
01/20/2000WO2000003022A2 Expression of herbicide tolerance genes in plant plastids
01/20/2000WO2000003021A2 Metabolically engineered microbial cell comprising a modified redox activity
01/20/2000WO2000003020A1 Metabolically engineered microbial cell with an altered metabolite production
01/20/2000WO2000003018A2 Antibiotic protein and method of production
01/20/2000WO2000003017A2 Enhancer elements for increased translation in plant plastids
01/20/2000WO2000003010A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon
01/20/2000WO2000003006A1 Sucrose biosynthesis genes and uses therefor
01/20/2000WO2000003005A2 Human checkpoint kinase
01/20/2000WO2000003004A2 Presenilin 2 specific ribozyme
01/20/2000WO2000002912A2 Disintegrin homologs
01/20/2000WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON)
01/20/2000WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
01/20/2000WO2000002581A1 Antigenic peptides derived from telomerase
01/20/2000WO1999060138A3 Regulated expression of pkc and/or srb1/psa1 in yeast
01/20/2000WO1999058690A3 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
01/20/2000WO1999058559A3 Factors affecting tumor necrosis factor receptor releasing enzyme activity
01/20/2000WO1999053067A8 Seed-coat promoters, genes and gene products
01/20/2000WO1999047650A3 PURIFIED RNA POLYMERASE FROM $i(ENTEROBACTER)
01/20/2000WO1999041386A3 Novel endo-xylogalacturonase
01/20/2000WO1999038964A3 Promoter regions of the mouse and human telomerase rna component genes
01/20/2000DE19921676A1 Aminosäuresequenz Amino acid sequence
01/20/2000DE19832334A1 Use of a glucosylglycerol phosphate synthase gene for glucosylglycerol production and generation of transgenic plants with increased tolerance against environmental stress
01/20/2000DE19831312A1 Transgenic mice useful for controlled in vivo cell ablation through recombinase activated expression of cell death inducible genes
01/20/2000CA2748996A1 Antigenic peptides derived from telomerase
01/20/2000CA2379034A1 Metabolically engineered microbial cell comprising a modified redox activity
01/20/2000CA2336710A1 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon
01/20/2000CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
01/20/2000CA2334043A1 Antibiotic protein and method of production
01/20/2000CA2333308A1 Enhancer elements for increased translation in plant plastids
01/20/2000CA2332700A1 Expression of herbicide tolerance genes in plant plastids
01/20/2000CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon)
01/20/2000CA2332497A1 Presenilin 2 specific ribozyme
01/20/2000CA2332346A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex
01/20/2000CA2332344A1 Method for identifying a presenilinase inhibitor
01/20/2000CA2332311A1 Disintegrin homologs
01/19/2000EP0972837A2 Ubiquitin specific protease like protein
01/19/2000EP0972836A2 Endonuclease
01/19/2000EP0972834A1 Induction promoter gene and secretory signal gene usable in schizosaccharomyces pombe, expression vectors having the same, and use thereof
01/19/2000EP0972197A1 Method for identifying inhibitors of jak2/cytokine receptor binding
01/19/2000EP0972075A2 Methods for assessing cardiovascular status and compositions for use thereof
01/19/2000EP0972071A1 Protease inhibtor assay
01/19/2000EP0972059A1 Nucleic acid molecules encoding starch phosphorylase from maize
01/19/2000EP0972053A1 Novel human serine carboxypeptidase
01/19/2000EP0972052A1 Keratinocyte derived kallikrein
01/19/2000EP0972051A1 Rna-dependent rna polymerase functioning preferably on rna matrix and promoter-dependent transcription process with said rna-dependent rna polymerase
01/19/2000EP0972050A1 Csk homologons kinaze (chk) for detecting and treating breast cancer
01/19/2000EP0972049A1 Microbial production of 1,2-propanediol from sugar
01/19/2000EP0972046A1 METHODS OF PRODUCING AND USING VIRULENCE ATTENUATED $i(poxR) MUTANT BACTERIA
01/19/2000EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
01/19/2000EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
01/19/2000EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis
01/19/2000EP0972024A1 A tumor suppressor designated ts10q23.3
01/19/2000EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES
01/19/2000EP0972022A2 Polynucleotides and polypeptides encoding receptors
01/19/2000EP0972016A1 A thermostable endo-beta-1,4-glucanase
01/19/2000EP0972015A1 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity
01/19/2000EP0972014A1 Laccase mutants
01/19/2000EP0972012A1 Immunosuppression
01/19/2000EP0972011A1 Cyclin-dependent protein kinase
01/19/2000EP0971948A2 Inhibitors for urokinase receptor
01/19/2000EP0971731A1 Suppression of malignancy utilizing ribonucleotide reductase r1
01/19/2000EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals
01/19/2000EP0779921A4 CLONED SstI/SacI RESTRICTION-MODIFICATION SYSTEM
01/19/2000EP0563191B2 Nucleotide sequences of soybean acyl-acp thioesterase genes
01/19/2000EP0515536B1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules
01/19/2000CN1242054A Process and composition for preparing D-aspartic acid
01/19/2000CN1242048A H mutant alpha-amylase enzymes
01/19/2000CN1242040A Prevention of back-staining in stone washing
01/19/2000CN1241941A Treatment of neurodegenerative conditions with nimesulide
01/19/2000CN1241634A Phytase formulation
01/19/2000CN1241633A Gene engineering process of preparing spinach chloroplast triose phosphate isomerase
01/18/2000US6015943 DNA sequences coding for a cinnamoyl CoA reductase and their uses in the field of regulating the lignin levels of plants
01/18/2000US6015939 Dna sequence encoding plant violaxanthin de-epoxidase; for production of transgenic plants with modified sensitivity to light, delayed flowering or larger flowers
01/18/2000US6015893 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis
01/18/2000US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents
01/18/2000US6015794 Trans-splicing ribozymes